Combining the suppression of GLI, FLT3, and PI3K, in vitro,demonstrated potent anti-leukemic effects in FLT3-mutated AML cells compared to FLT3 wild-type AML cells [20]. The gene discussed is GLI1; the disease is acute myeloid leukemia.